Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107)
Grupo Espanol de Tumores Neuroendocrinos
Rocio Garcia-Carbonero; Marta Benavent; Paula Jimenez-Fonseca; Teresa Alonso-Gordoa; Alex Teulé; Ana Custodio; Salvatore Tafuto; Adelaida La Casta; Francesca Spada; Carlos López; Toni Ibrahim; Vega Iranzo; Pilar García-Alfonso; Encarna González-Flores; María José Villanueva Silva; Enrique Grande; Francesco Panzuto; Guillermo Crespo; Miguel Navarro; Daniel Castellano; Jorge Hernando; Rocío Morales-Herrero; German Iglesias Álvarez; Beatriz Soldevilla; Jaume Capdevila